SCHEMBL24088145

SCHEMBL24088145

N#Cc1c(C(F)(F)F)cc(=O)[nH]c1SCc1cc(F)c(O)c(F)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 9/20 0.62
▸ ALDH1A1 P00352 13/20 0.51
▸ MAPT P10636 2/20 0.51
▸ TSHR P16473 2/20 0.39
▸ GAA P10253 9/20 0.39
▸ HPGD P15428 9/20 0.39
▸ GLA P06280 7/20 0.39
▸ TP53 P04637 2/20 0.39
▸ HTT P42858 4/20 0.37
▸ KMT2A Q03164 4/20 0.37
▸ HSD17B10 Q99714 2/20 0.36
▸ POLB P06746 1/20 0.36
▸ MEN1 O00255 2/20 0.35
▸ TDP1 Q9NUW8 1/20 0.34
▸ LMNA P02545 2/20 0.34
▸ CRHBP P24387 1/20 0.34
▸ CRHR2 Q13324 1/20 0.34
▸ ATM Q13315 1/20 0.34
▸ DAO P14920 1/20 0.34
▸ GFER P55789 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26847326 0.88 KDM4E (0.59) KDM4EALDH1A1MAPTTSHRGAA
SCHEMBL20340039 0.81 KDM4E (0.62) KDM4EALDH1A1MAPTTSHRGAA
SCHEMBL20339568 0.81 KDM4E (0.61) KDM4EALDH1A1MAPTTSHRGAA
SCHEMBL24087880 0.78 ALDH1A1 (0.42) KDM4EALDH1A1MAPTTSHRGAA
SCHEMBL20339496 0.77 KDM4E (0.70) KDM4EALDH1A1MAPTTSHRGAA
SCHEMBL23850213 0.77 KDM4E (0.65) KDM4EALDH1A1MAPTTSHRGAA
SCHEMBL20340200 0.77 KDM4E (0.62) KDM4EALDH1A1MAPTHPGDKMT2A
SCHEMBL20350815 0.77 KDM4E (0.68) KDM4EALDH1A1MAPTTSHRGAA
SCHEMBL20339508 0.77 KDM4E (1.00) KDM4EALDH1A1MAPTTSHRGAA
SCHEMBL24087891 0.76 KDM4E (0.58) KDM4EALDH1A1MAPTTSHRGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230381177-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE TES PHARMA S.R.L. (IT) 2023-11-30 — — US disclosed
US-20210379069-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE TES PHARMA S R L (IT) 2021-12-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230381177-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE ACMSD, GLS, ALDH7A1 KDM4E 1110/4885ALDH1A1 171/4885MAPT 1263/4885
US-20210379069-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE ACMSD, GLS, ALDH7A1 KDM4E 1110/4885ALDH1A1 171/4885MAPT 1263/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback